CLASS II Device recall · Reported 12 Sep 2018 · FDA Enforcement Report

Foundation Modular Femoral Stem recalled by Encore Medical

Encore Medical is recalling Foundation Modular Femoral Stem, distributed in Arizona, Missouri, Mississippi, New York, Oklahoma, Utah. The recall was initiated on 14 May 2018 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesAll. Lots-866A1011, 866A1022
Quantity recalled12

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2967-2018
FDA event ID
80692
Recalling firm
Encore Medical, Austin, TX
Classification
Class II
Status
Terminated
Recall initiated
14 May 2018
FDA classified
31 Aug 2018
Reported
12 Sep 2018
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Device Malfunction

Timeline

14 May 2018Recall initiated by company
31 Aug 2018Classified by FDA+109 days
12 Sep 2018Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

After receipt of a product complaint for the labeling, it was determined that this device does not have FDA clearance.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

Foundation Modular Femoral Stem, Part Number, 220-10-110. Knee prosthesis component. The Foundation Revision Knee is a total knee system indicated as knee joint replacement for patients suffering from pain and dysfunction.

Where it was distributed

U.S. Distribution to states of: AZ, MO, MS, NY, OK, and UT; internationally to: Japan.

ArizonaMissouriMississippiNew YorkOklahomaUtah

Questions about this recall

Why was it recalled?

After receipt of a product complaint for the labeling, it was determined that this device does not have FDA clearance.

Which lots are affected?

All. Lots-866A1011, 866A1022

Where was it sold?

U.S. Distribution to states of: AZ, MO, MS, NY, OK, and UT; internationally to: Japan.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Encore Medical

All 99

Other Hip & Knee Implants recalls

All 3,097